Nortech Systems, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US6565531042
USD
7.05
0.18 (2.64%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Nortech Systems, Inc. stock-summary
stock-summary
Nortech Systems, Inc.
Pharmaceuticals & Biotechnology
Nortech Systems Incorporated is an electronic manufacturing services (EMS) company. The Company offers a range of value-added engineering, technical and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management and post-market services. The Company's segment is Contract Manufacturing. The Company's manufacturing and engineering services include medical devices, printed circuit board assemblies, wire and cable assemblies, and electromechanical assemblies. The Company's manufacturing facilities are located at Bemidji, Blue Earth, Merrifield, Eden Prairie, Milaca and Mankato in Minnesota; Augusta in Wisconsin; Monterrey in Mexico, and Suzhou in China. The Company serves approximately three markets within the EMS industry, such as Aerospace and Defense, Medical/Life Sciences and the Industrial market, which includes industrial equipment, transportation, vision, agriculture, oil and gas.
Company Coordinates stock-summary
Company Details
7550 Meridian Cir N Ste 150 , MAPLE GROVE MN : 55369-4932
stock-summary
Tel: 1 952 3452244
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 4 Schemes (1.71%)

Foreign Institutions

Held by 2 Foreign Institutions (0.1%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
David Kunin
Chairman of the Board
Mr. Jay Miller
President, Chief Executive Officer, Director
Ms. Kathleen Iverson
Director
Dr. Danny Sachs
Director
Mr. Philip Smith
Director
Kenneth Larson
Independent Director
Mr. Richard Perkins
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
31 Million
(Quarterly Results - Jun 2025)
Net Profit:
0 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 26 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.37

stock-summary
Return on Equity

-7.41%

stock-summary
Price to Book

0.78